Equinor ASA vs Revolution Medicines Inc. Common Stock — how do they compare? Equinor ASA trades at $43.61 (market cap $101.62B), while Revolution Medicines Inc. Common Stock trades at $186.59 (market cap $40.32B). The key difference: Equinor ASA is far larger — about 2.5× Revolution Medicines Inc. Common Stock's market cap, and Equinor ASA pays a 3.63% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Equinor ASA for 59 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| EQNR | RVMD | |
|---|---|---|
Market Cap | $101.62B | $40.32B |
Volume | 4,991,782 | 4,855,734 |
Sector | Energy | Health |
52-Week High | $45.75 | $221.15 |
52-Week Low | $22.41 | $47.50 |
Typical Hold Time | 59 Days | 0 Days |
Enterprise Value | $110.31B | $37.02B |
Dividend Yield | 3.63% | — |
Signals from Pluang's Aura AI — not financial advice
EQNR trades at $41.61, down 3.26% today, with a bearish technical outlook and mixed fundamental performance. The stock shows attractive valuation metrics including P/E of 11.63 and EV/EBITDA of 2.39, but faces declining profit margins from 19.29% in 2022 to 4.76% in 2025. Recent earnings show two beats and one miss, while analyst consensus remains positive with a $87.50 price target representing significant upside potential from current levels.
The investment case balances deep value characteristics against operational headwinds. While valuation appears compelling with strong cash flows and dividend payments, investors face risks from volatile energy markets and margin compression. The 112% upside to consensus target suggests Wall Street sees substantial recovery potential if operational performance improves.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2021 (52% oil) and ended the year with 5.4 billion barrels of proven reserves (49% oil). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.
Read more on EQNR →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →